Vertex Pharmaceuticals Tokenized Stock (Reality)
RVRTX

540.00
$
1.17 %
Change 24h
Market Cap
$ 4882.7
Volume 24h
$ 898.98
Circulating Supply
9
Total Supply
9
RVRTX
$
# Exchange Pair Price Volume 24h

Description

Vertex Pharmaceuticals is a U.S. biopharmaceutical enterprise engaged in the development and commercialization of prescription drugs. Its primary approved products are used to treat cystic fibrosis. Additionally, the company has clinical-stage product candidates in sickle cell disease, thalassemia, acute pain, and specific kidney diseases. The company combines internal R&D platforms with external corporate partnerships to advance the clinical validation and regulatory review processes of targeted therapies.
We Use Cookies
By continuing to use our site, you accept our use of cookies